Loading stock data…
HCA
$433.09-1.36 (-0.31%)
Market ClosedLast close May 1
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HCA Healthcare, Inc. in the Healthcare sector is trading at $433.09. The stock is currently 22% below its 52-week high of $556.52, remaining 5.1% below its 200-day moving average. Technical signals show oversold RSI of 22 and bearish MACD signal, explaining why HCA maintains its current current market pressure. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Oversold momentum (RSI 22) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$433.09
Potential Downside
110.9%
Whystock Fair Value$-47.22
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus21 analysts
Buy
Mean target$513.10+18.5%
Range$396.00 – $635.00
Fundamentals
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$105.40B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.64
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.37
Div Yield
Strong income play. Yield provides a meaningful total return floor.
66.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-99.07%
Volume
Today's trading volume
896,681
Recent News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
HCA Healthcare (HCA): A Target Cut, But Execution Still Gets Credit
With stock buybacks of $9.21 billion in the 12 months through September 2025, HCA Healthcare, Inc. (NYSE:HCA) is among the 20 Stocks with the Biggest Share Buybacks. HCA Healthcare, Inc. (NYSE:HCA) received a revised analyst outlook on April 28 when Bernstein lowered its price target to $503 from $541 while maintaining a Market Perform rating. The […]
HCA Healthcare Q1 Earnings Call Highlights
HCA Healthcare (NYSE:HCA) executives said the company’s first quarter of 2026 was shaped by an unusually mild respiratory season and a broad winter storm that reduced volumes early in the quarter, while higher-than-expected net benefits from Medicaid supplemental payment programs helped offset some
How The Investment Story For HCA Healthcare (HCA) Is Shifting Around AI And Medicaid Assumptions
HCA Healthcare’s modeled fair value has been trimmed from US$543.05 to US$535.00. This reflects an US$8 target cut that signals a slightly cooler stance in some updated research. That change comes as analysts split between raising and lowering price targets, weighing AI related efficiency potential, Medicaid related earnings support, and execution on guidance. Read on to see what is driving these shifting views and how you can track the evolving story around HCA’s valuation targets over...
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks fell late Monday afternoon with the NYSE Health Care Index easing 0.2% and the St